Atherosclerosis
Volume 209, Issue 1 , Pages 111-117 , March 2010

Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters

  • Yanwen Wang

      Affiliations

    • Institute for Nutrisciences and Health, National Research Council Canada, Charlottetown, PE, Canada
    • Department of Biomedical Sciences, University of Prince Edward Island, Charlottetown, PE, Canada
    • Corresponding Author InformationCorresponding author at: Institute for Nutrisciences and Health, National Research Council Canada, 550 University Avenue, Charlottetown, PE, Canada C1A 4P3. Tel.: +1 902 566 7953; fax: +1 902 566 7468.
    • ,
  • Xiaoming Jia

      Affiliations

    • Institute for Nutrisciences and Health, National Research Council Canada, Charlottetown, PE, Canada
    • ,
  • Khadija Ghanam

      Affiliations

    • Institute for Nutrisciences and Health, National Research Council Canada, Charlottetown, PE, Canada
    • Department of Biomedical Sciences, University of Prince Edward Island, Charlottetown, PE, Canada
    • ,
  • Cécile Beaurepaire

      Affiliations

    • Institute for Nutrisciences and Health, National Research Council Canada, Charlottetown, PE, Canada
    • ,
  • Jeffrey Zidichouski

      Affiliations

    • Institute for Nutrisciences and Health, National Research Council Canada, Charlottetown, PE, Canada
    • Department of Biomedical Sciences, University of Prince Edward Island, Charlottetown, PE, Canada
    • ,
  • Lisa Miller

      Affiliations

    • Department of Pathology and Microbiology, University of Prince Edward Island, Charlottetown, PE, Canada

Received 11 July 2009 ,Revised 10 August 2009 ,Accepted 25 August 2009.

References 

  1. Zeng XH, Zeng XJ, Li YY. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2003;92:173–176
  2. Jagetia GC, Baliga MS. Effect of Alstonia scholaris in enhancing the anticancer activity of berberine in the Ehrlich ascites carcinoma-bearing mice. J Med Food. 2004;7:235–244
  3. Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004;10:1344–1351
  4. Cicero AF, Rovati LC, Setnikar I. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation. Arzneimittelforschung. 2007;57:26–30
  5. Abidi P, Chen W, Kraemer FB, Li H, Liu J. The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms. J Lipid Res. 2006;47:2134–2147
  6. Tang LQ, Wei W, Chen LM, Liu S. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol. 2006;108:109–115
  7. Vanstone CA, Raeini-Sarjaz M, Parsons WE, Jones PJ. Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons. Am J Clin Nutr. 2002;76:1272–1278
  8. Wang Y, Jones PJ, Ausman LM, Lichtenstein AH. Soy protein reduces triglyceride levels and triglyceride fatty acid fractional synthesis rate in hypercholesterolemic subjects. Atherosclerosis. 2004;173:269–275
  9. Jenkins DJ, Axelsen M, Kendall CW, Augustin LS, Vuksan V, Smith U. Dietary fibre, lente carbohydrates and the insulin-resistant diseases. Br J Nutr. 2000;83(Suppl 1):S157–S163
  10. Rutishauser J. The role of statins in clinical medicine – LDL – cholesterol lowering and beyond. Swiss Med Wkly. 2006;136:41–49
  11. Chang HM, But PPH. Pharmacology and applications of chinese materia medica. Farrer Road, Singapore: World Scientific Publishing Co. Pte. Ltd.; 2000;p. 60
  12. Oshiba S, Ueno H, Mihara H, Okamoto S. Effect of berberine on bile secretion. Nihon Univ J Med. 1974;16:69–79
  13. Vartazaryan BA, Koltochnik EE. Choleretic action of berberine Sb Nauchn Tr Vladivostoksk. Med Inst. 1964;2:113–115
  14. Mikes V, Kovar J. Interaction of liposomes with homologous series of fluorescent berberine derivatives. New cationic probes for measuring membrane potential. Biochim Biophys Acta. 1981;640:341–351
  15. Megyesi M, Biczok L. Berberine alkaloid as a sensitive fluorescent probe for bile salt aggregates. J Phys Chem B. 2007;111:5635–5639
  16. Miettinen TA, Vuoristo M, Nissinen M, Jarvinen HJ, Gylling H. Serum, biliary, and fecal cholesterol and plant sterols in colectomized patients before and during consumption of stanol ester margarine. Am J Clin Nutr. 2000;71:1095–1102
  17. Korpela R, Tuomilehto J, Hogstrom P, et al. Safety aspects and cholesterol-lowering efficacy of low fat dairy products containing plant sterols. Eur J Clin Nutr. 2006;60:633–642
  18. Jia X, Chen Y, Zidichouski J, Zhang J, Sun C, Wang Y. Co-administration of berberine and plant stanols synergistically reduces plasma cholesterol in rats. Atherosclerosis. 2008;
  19. Suckling KE, Jackson B. Animal models of human lipid metabolism. Prog Lipid Res. 1993;32:1–24
  20. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939–1951
  21. Ntanios FY, MacDougall DE, Jones PJ. Gender effects of tall oil versus soybean phytosterols as cholesterol-lowering agents in hamsters. Can J Physiol Pharmacol. 1998;76:780–787
  22. Wang YW, Jones PJ, Pischel I, Fairow C. Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters. Lipids. 2003;38:165–170
  23. Kris-Etherton PM, Dietschy J. Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies. Am J Clin Nutr. 1997;65:1590S–1596S
  24. Ntanios FY, Jones PJ. Dietary sitostanol reciprocally influences cholesterol absorption and biosynthesis in hamsters and rabbits. Atherosclerosis. 1999;143:341–351
  25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  26. Jia X, Ebine N, Demonty I, et al. Hypocholesterolaemic effects of plant sterol analogues are independent of ABCG5 and ABCG8 transporter expressions in hamsters. Br J Nutr. 2007;98:550–555
  27. Field FJ, Born E, Mathur SN. Stanol esters decrease plasma cholesterol independently of intestinal ABC sterol transporters and Niemann-Pick C1-Like 1 protein gene expression. J Lipid Res. 2004;45:2252–2259
  28. Vlahcevic ZR, Pandak WM, Heuman DM, Hylemon PB. Function and regulation of hydroxylases involved in the bile acid biosynthesis pathways. Semin Liver Dis. 1992;12:403–419
  29. Matsuzaki Y, Bouscarel B, Ikegami T, et al. Selective inhibition of CYP27A1 and of chenodeoxycholic acid synthesis in cholestatic hamster liver. Biochim Biophys Acta. 2002;1588:139–148
  30. Plosch T, Kosters A, Groen AK, Kuipers F. The ABC of hepatic and intestinal cholesterol transport. Handbook Exp Pharmacol. 2005;465–482
  31. Plosch T, Kruit JK, Bloks VW, et al. Reduction of cholesterol absorption by dietary plant sterols and stanols in mice is independent of the Abcg5/8 transporter. J Nutr. 2006;136:2135–2140
  32. Calpe-Berdiel L, Escola-Gil JC, Ribas V, Navarro-Sastre A, Garces-Garces J, Blanco-Vaca F. Changes in intestinal and liver global gene expression in response to a phytosterol-enriched diet. Atherosclerosis. 2005;181:75–85
  33. Kesaniemi YA, Miettinen TA. Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population. Eur J Clin Invest. 1987;17:391–395
  34. Wang Y, Jones PJ, Woollett LA, et al. Effects of chenodeoxycholic acid and deoxycholic acid on cholesterol absorption and metabolism in humans. Transl Res. 2006;148:37–45
  35. Matthan NR, Pencina M, Larocque JM, et al. Alterations in cholesterol absorption and synthesis characterize Framingham offspring study participants with coronary heart disease. J Lipid Res. 2009;
  36. Volger OL, van der Boom H, de Wit EC, et al. Dietary plant stanol esters reduce VLDL cholesterol secretion and bile saturation in apolipoprotein E*3-Leiden transgenic mice. Arterioscler Thromb Vasc Biol. 2001;21:1046–1052
  37. Repa JJ, Turley SD, Quan G, Dietschy JM. Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption. J Lipid Res. 2005;46:779–789
  38. Jeu L, Cheng JW. Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor. Clin Ther. 2003;25:2352–2387
  39. van Heek M, Austin TM, Farley C, Cook JA, Tetzloff GG, Davis HR. Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters. Diabetes. 2001;50:1330–1335
  40. Stein E. Results of phase 1/II clinical trials with ezetimibe, a novel selective cholesterol absorption inhibitor. Eur Heart J. 2001;3(Suppl):E11–E16
  41. Telford DE, Sutherland BG, Edwards JY, Andrews JD, Barrett PH, Huff MW. The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin. J Lipid Res. 2007;48:699–708
  42. Ntanios FY, Jones PJ. Effects of variable dietary sitostanol concentrations on plasma lipid profile and phytosterol metabolism in hamsters. Biochim Biophys Acta. 1998;1390:237–244
  43. Wang Y, Ebine N, Jia X, Jones PJ, Fairow C, Jaeger R. Very long chain fatty acids (policosanols) and phytosterols affect plasma lipid levels and cholesterol biosynthesis in hamsters. Metabolism. 2005;54:508–514
  44. Egger M, Smith GD, Pfluger D, Altpeter E, Elwood PC. Triglyceride as a risk factor for ischaemic heart disease in British men: effect of adjusting for measurement error. Atherosclerosis. 1999;143:275–284
  45. Assmann G. Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management. Am J Cardiol. 2001;87:2B–7B
  46. Brusq JM, Ancellin N, Grondin P, et al. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res. 2006;47:1281–1288
  47. Lee YS, Kim WS, Kim KH, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006;55:2256–2264

PII: S0021-9150(09)00712-6

doi: 10.1016/j.atherosclerosis.2009.08.050

Atherosclerosis
Volume 209, Issue 1 , Pages 111-117 , March 2010

Article Tools

* Image Usage & Resolution